SEC 13F Intelligence

Birchview Capital, LP / NTLA

Birchview Capital, LP’s Intellia Therapeutics Inc Position

Does Birchview Capital, LP own Intellia Therapeutics Inc (NTLA)? Yes — 445.4K shares worth $6M (+3.25% of its 13F portfolio) as of Q1 2026, up from 315.4K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
445.4K
% of Portfolio
+3.25%
Quarters Held
4
currently held

Position History NTLA

Reported value by quarter
Q2 ’25: $562,800Q2 ’25Q3 ’25: $1MQ3 ’25Q4 ’25: $3MQ4 ’25Q1 ’26: $6MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026445.4K$6M+3.25%
Q4 2025315.4K$3M+1.66%
Q3 202560.0K$1M+0.78%
Q2 202560.0K$562,800+0.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of NTLA.